vs
Pebblebrook Hotel Trust（PEB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Pebblebrook Hotel Trust的1.8倍（$622.0M vs $345.7M），Royalty Pharma plc净利率更高（34.4% vs -5.3%，领先39.8%），Pebblebrook Hotel Trust同比增速更快（7.9% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -6.7%）
Pebblebrook Hotel Trust是一家公开上市的房地产投资信托，主要在美国核心城市及休闲目的地持有、运营并投资高端、奢华及精品酒店物业，服务商务与休闲旅客，聚焦高需求市场以推动长期价值增长。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PEB vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.8倍
$345.7M
营收增速更快
PEB
高出3.2%
4.8%
净利率更高
RPRX
高出39.8%
-5.3%
两年增速更快
RPRX
近两年复合增速
-6.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $345.7M | $622.0M |
| 净利润 | $-18.4M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 2.3% | 62.4% |
| 净利率 | -5.3% | 34.4% |
| 营收同比 | 7.9% | 4.8% |
| 净利润同比 | 31.8% | 2.9% |
| 每股收益（稀释后） | $-0.26 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PEBRPRX
| Q1 26 | $345.7M | — | ||
| Q4 25 | $349.0M | $622.0M | ||
| Q3 25 | $398.7M | $609.3M | ||
| Q2 25 | $407.5M | $578.7M | ||
| Q1 25 | $320.3M | $568.2M | ||
| Q4 24 | $337.6M | $593.6M | ||
| Q3 24 | $404.5M | $564.7M | ||
| Q2 24 | $397.1M | $537.3M |
净利润PEBRPRX
| Q1 26 | $-18.4M | — | ||
| Q4 25 | $-17.9M | $214.2M | ||
| Q3 25 | $-33.1M | $288.2M | ||
| Q2 25 | $18.1M | $30.2M | ||
| Q1 25 | $-32.9M | $238.3M | ||
| Q4 24 | $-50.5M | $208.2M | ||
| Q3 24 | $43.7M | $544.0M | ||
| Q2 24 | $30.9M | $102.0M |
营业利润率PEBRPRX
| Q1 26 | 2.3% | — | ||
| Q4 25 | 2.5% | 62.4% | ||
| Q3 25 | -2.6% | 70.1% | ||
| Q2 25 | 12.9% | 36.3% | ||
| Q1 25 | -2.3% | 94.0% | ||
| Q4 24 | -6.7% | 60.9% | ||
| Q3 24 | 11.6% | — | ||
| Q2 24 | 15.4% | 50.2% |
净利率PEBRPRX
| Q1 26 | -5.3% | — | ||
| Q4 25 | -5.1% | 34.4% | ||
| Q3 25 | -8.3% | 47.3% | ||
| Q2 25 | 4.4% | 5.2% | ||
| Q1 25 | -10.3% | 41.9% | ||
| Q4 24 | -15.0% | 35.1% | ||
| Q3 24 | 10.8% | 96.3% | ||
| Q2 24 | 7.8% | 19.0% |
每股收益（稀释后）PEBRPRX
| Q1 26 | $-0.26 | — | ||
| Q4 25 | $-0.22 | $0.49 | ||
| Q3 25 | $-0.37 | $0.67 | ||
| Q2 25 | $0.06 | $0.07 | ||
| Q1 25 | $-0.37 | $0.55 | ||
| Q4 24 | $-0.47 | $0.46 | ||
| Q3 24 | $0.24 | $1.21 | ||
| Q2 24 | $0.16 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.4B | $9.7B |
| 总资产 | $5.3B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PEBRPRX
| Q1 26 | $196.2M | — | ||
| Q4 25 | $184.2M | $618.7M | ||
| Q3 25 | $223.2M | $938.9M | ||
| Q2 25 | $256.1M | $631.9M | ||
| Q1 25 | $208.1M | $1.1B | ||
| Q4 24 | $206.7M | $929.0M | ||
| Q3 24 | $134.0M | $950.1M | ||
| Q2 24 | $101.7M | $1.8B |
总债务PEBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $9.0B | ||
| Q3 25 | $2.2B | $8.9B | ||
| Q2 25 | $2.2B | $8.0B | ||
| Q1 25 | $2.2B | $7.6B | ||
| Q4 24 | $2.2B | $7.6B | ||
| Q3 24 | $2.2B | $7.6B | ||
| Q2 24 | $2.2B | $7.6B |
股东权益PEBRPRX
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $9.7B | ||
| Q3 25 | $2.5B | $9.6B | ||
| Q2 25 | $2.6B | $9.5B | ||
| Q1 25 | $2.6B | $9.8B | ||
| Q4 24 | $2.7B | $10.3B | ||
| Q3 24 | $2.8B | $10.3B | ||
| Q2 24 | $2.7B | $9.8B |
总资产PEBRPRX
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.3B | $19.6B | ||
| Q3 25 | $5.6B | $19.3B | ||
| Q2 25 | $5.7B | $18.3B | ||
| Q1 25 | $5.7B | $17.6B | ||
| Q4 24 | $5.7B | $18.2B | ||
| Q3 24 | $5.7B | $18.0B | ||
| Q2 24 | $5.7B | $17.7B |
负债/权益比PEBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.86× | 0.92× | ||
| Q3 25 | 0.89× | 0.93× | ||
| Q2 25 | 0.85× | 0.84× | ||
| Q1 25 | 0.85× | 0.78× | ||
| Q4 24 | 0.83× | 0.74× | ||
| Q3 24 | 0.80× | 0.74× | ||
| Q2 24 | 0.80× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $114.5M | — |
| 自由现金流率自由现金流/营收 | 33.1% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PEBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $249.7M | $827.1M | ||
| Q3 25 | $77.6M | $702.6M | ||
| Q2 25 | $90.5M | $364.0M | ||
| Q1 25 | $50.3M | $596.1M | ||
| Q4 24 | $275.0M | $742.5M | ||
| Q3 24 | $76.1M | $703.6M | ||
| Q2 24 | $83.7M | $658.2M |
自由现金流PEBRPRX
| Q1 26 | $114.5M | — | ||
| Q4 25 | $152.3M | — | ||
| Q3 25 | $6.8M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $146.3M | — | ||
| Q3 24 | $-24.8M | — | ||
| Q2 24 | — | — |
自由现金流率PEBRPRX
| Q1 26 | 33.1% | — | ||
| Q4 25 | 43.6% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 43.3% | — | ||
| Q3 24 | -6.1% | — | ||
| Q2 24 | — | — |
资本支出强度PEBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 27.9% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 24.9% | — | ||
| Q2 24 | — | — |
现金转化率PEBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 5.01× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 1.74× | 1.29× | ||
| Q2 24 | 2.70× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEB
| Room | $214.5M | 62% |
| Food and beverage | $91.1M | 26% |
| Other | $40.0M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
